Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
AbbVie Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 62.10||$ 71.60|
|Low||$ 57.53||$ 45.45|
The current last sale of $61.20 is 34.65% Higher thanthe 52 week low.
ETFs with ABBV as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.65%||Market Vectors Pharmaceutical ETF (PPH)||-5.66 (-8.69%)|
|3.47%||SPDR Select Sector Fund - Health Care (XLV)||-0.46 (-0.64%)|
|3.27%||iShares U.S. Healthcare ETF (IYH)||-3.50 (-2.32%)|
|3.12%||Vanguard Health Care ETF - DNQ (VHT)||-2.69 (-2.03%)|
|2.96%||WisdomTree U.S. Quality Dividend Growth Fund (DGRW)||+0.55 (1.77%)|
Company Description (as filed with the SEC)
AbbVie(1) was incorporated in Delaware on April 10, 2012. On January 1, 2013, AbbVie became an independent company as a result of the distribution by Abbott Laboratories (Abbott) of 100 percent of the outstanding common stock of AbbVie to Abbott's shareholders. AbbVie's common stock began trading "regular-way" under the ticker symbol "ABBV" on the New York Stock Exchange on January 2, 2013. Overview AbbVie is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address some of the world's most complex and serious diseases. ... More ...
Where does ABBV fit in the risk graph?
|Annual EPS Est:||$4.29|
|Quarterly EPS Est:||1.12|